| CTOR |
CITIUS ONCOLOGY, INC. |
19 Sep 2025 |
1 |
$0 |
4/A |
Chief Executive Officer, Director |
22 Dec 2025, 16:10 |
| CTOR |
CITIUS ONCOLOGY, INC. |
19 Sep 2025 |
1 |
$0 |
4/A |
Chief Executive Officer, Director |
01 Dec 2025, 16:10 |
| CTXR |
Citius Pharmaceuticals, Inc. |
08 Aug 2025 |
4 |
$0 |
4 |
Chief Executive Officer, Director |
23 Sep 2025, 16:05 |
| CTOR |
CITIUS ONCOLOGY, INC. |
12 Dec 2024 |
1 |
$0 |
4 |
Chief Executive Officer, Director |
16 Dec 2024, 16:05 |
| CTXR |
Citius Pharmaceuticals, Inc. |
07 Nov 2024 |
1 |
$0 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
12 Nov 2024, 17:00 |
| CTXR |
Citius Pharmaceuticals, Inc. |
14 Aug 2024 |
4 |
$0 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
27 Sep 2024, 17:26 |
| CTOR |
CITIUS ONCOLOGY, INC. |
12 Aug 2024 |
1 |
$0 |
4/A |
Chief Executive Officer, Director |
30 Aug 2024, 16:05 |
| CTOR |
CITIUS ONCOLOGY, INC. |
12 Aug 2024 |
0 |
$0 |
3 |
Chief Executive Officer, Director |
14 Aug 2024, 18:21 |
| THAR |
Tharimmune, Inc. |
09 Aug 2024 |
1 |
$0 |
4 |
Director |
12 Aug 2024, 17:18 |
| CTXR |
Citius Pharmaceuticals, Inc. |
03 Apr 2024 |
2 |
$0 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
05 Apr 2024, 16:05 |
| CTXR |
Citius Pharmaceuticals, Inc. |
10 Oct 2023 |
1 |
$0 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
12 Oct 2023, 16:15 |
| THAR |
Tharimmune, Inc. |
07 Nov 2022 |
1 |
$0 |
4 |
Director |
09 Nov 2023, 19:48 |
| CTXR |
Citius Pharmaceuticals, Inc. |
04 Oct 2022 |
0 |
$0 |
4/A |
Executive Chairman, Director, 10%+ Owner |
15 Nov 2022, 15:05 |
| THAR |
Hillstream BioPharma Inc. |
21 Mar 2022 |
1 |
$0 |
4 |
Director |
23 Mar 2022, 16:15 |
| THAR |
Hillstream BioPharma Inc. |
14 Jan 2022 |
3 |
+$115,946 |
4 |
Director |
18 Jan 2022, 15:09 |
| THAR |
Hillstream BioPharma Inc. |
11 Jan 2022 |
0 |
$0 |
3 |
Director |
11 Jan 2022, 20:41 |
| CTXR |
Citius Pharmaceuticals, Inc. |
11 Oct 2021 |
1 |
$0 |
4 |
Executive Chairman, Director, 10%+ Owner |
13 Oct 2021, 17:25 |
| CTXR |
Citius Pharmaceuticals, Inc. |
22 Jul 2021 |
1 |
$0 |
4 |
Executive Chairman, Director, 10%+ Owner |
26 Jul 2021, 17:02 |